Identification and Clinical Validation of High HSP60 Expression Predicts Poor Prognosis in Patients with Ovarian Cancer
High HSP60 expression is associated with poor prognosis and aggressive tumor characteristics in ovarian cancer. HSP60 may serve as a valuable biomarker for prognosis and a potential therapeutic target. Further randomized clinical trials are warranted to explore its role in ovarian cancer progression and treatment strategies.
Authors
- Jie Deng (ORCID: https://orcid.org/0000-0003-0249-1969)
- Chaolin Huang
- Shaoxing Li (ORCID: https://orcid.org/0009-0009-0866-3638)
- Hua Zhang (ORCID: https://orcid.org/0000-0001-5170-9851)
- Min Zheng (ORCID: https://orcid.org/0000-0002-3319-5647)
Institutions
- First Affiliated Hospital of Chengdu Medical College (CN)
Publication Details
- Journal
- International Journal of General Medicine
- Published
- 2025-01-01
- DOI
- https://doi.org/10.2147/ijgm.s499524
- Citations
- 1
- Primary Topic
- Heat shock proteins research
- Type
- article
- Field-Weighted Citation Impact
- 0.81